McLean Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $283K | Sell |
|
|||||
|
2025
Q2 | $302K | Sell |
|
|||||
|
2025
Q1 | $346K | Sell |
|
|||||
|
2024
Q4 | $377K | Buy |
|
|||||
|
2024
Q3 | $348K | Buy |
|
|||||
|
2024
Q2 | $261K | Sell |
|
|||||
|
2024
Q1 | $373K | Sell |
|
|||||
|
2023
Q4 | $388K | Sell |
|
|||||
|
2023
Q3 | $422K | Sell |
|
|||||
|
2023
Q2 | $483K | Buy |
|
|||||
|
2023
Q1 | $519K | Sell |
|
|||||
|
2022
Q4 | $555K | Buy |
|
|||||
|
2022
Q3 | $536K | Sell |
|
|||||
|
2022
Q2 | $590K | Sell |
|
|||||
|
2022
Q1 | $568K | Buy |
|
|||||
|
2021
Q4 | $496K | Buy |
|
|||||
|
2021
Q3 | $426K | Buy |
|
|||||
|
2021
Q2 | $422K | Buy |
|
|||||
|
2021
Q1 | $410K | Sell |
|
|||||
|
2020
Q4 | $397K | Buy |
|